SEC Form 4 · accession 0001209191-19-017761
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip D Gregory
Officer — Chief Scientific Officer
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2019 | M | 600 | $50.51 | A | 33,692 | D | |
| Common Stock | Mar 5, 2019 | M | 700 | $75.60 | A | 34,392 | D | |
| Common StockF2 | Mar 5, 2019 | S | 600 | $146.015 | D | 33,792 | D | |
| Common StockF3 | Mar 5, 2019 | S | 300 | $147.3767 | D | 33,492 | D | |
| Common StockF4 | Mar 5, 2019 | S | 300 | $148.5783 | D | 33,192 | D | |
| Common StockF5 | Mar 5, 2019 | S | 600 | $149.1392 | D | 32,592 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $50.51 | Mar 5, 2019 | M | 600 | D | — | Mar 1, 2026 | Common Stock | 600 | 12,200 | D |
| Stock Option (right to buy)F7 | $75.60 | Mar 5, 2019 | M | 700 | D | — | Feb 1, 2027 | Common Stock | 700 | 28,500 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- F2The range in prices for the transaction reported on this line was $146.00 to $146.06. The average weighted price was $146.015. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $147.15 to $147.54. The average weighted price was $147.3767. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $148.555 to $148.61. The average weighted price was $148.5783. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range in prices for the transaction reported on this line was $149.01 to $149.32. The average weighted price was $149.1392. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017 and in 36 equal monthly installments thereafter.
- F7This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2018 and in 36 equal monthly installments thereafter.